Visit the Oxoid web site
Click on the advert above to visit the company web site

Product category: Clinical chemistry analysis
News Release from: Oxoid | Subject: D-Dimer and Thrombo-Wellcotest
Edited by the Laboratorytalk Editorial Team on 06 July 2006

Rapid detection of bleeding and clotting
disorders

Oxoid has extended its range of rapid diagnostic tests to include two coagulation tests for use in the diagnosis of bleeding and clotting disorders

The D-Dimer test (product code: 30852501) and Thrombo-Wellcotest (product code: 30852601) detect either primary or secondary activation of the fibrinolytic system Increased levels of fibrinogen or fibrin degradation products are found in conditions such as thromboembolic disease, myocardial infarction, post-operative vein thrombosis, disseminated intravascular coagulation, glomerulonephritis and certain pregnancy disorders

D-Dimer detects cross-linked fibrin degradation products in plasma or serum, which is a marker for secondary fibrinolysis.

Thrombo-Wellcotest detects fibrin or fibrinogen degradation products in serum or urine, greatly elevated levels of which are associated with thrombotic episodes of any kind.

Used together, they offer a positive predictive value of almost 100%.

These rapid latex agglutination tests provide qualitative or semi quantitative results within just three minutes, ensuring prompt diagnosis and optimal patient care.

Furthermore, since they are extremely quick and simple to perform, they fit into routine laboratory testing with ease - saving on time and laboratory resources.

Results are clearly visible and easy to interpret in normal light, without the need for specialised equipment. Request a free brochure from Oxoid ...

Oxoid: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Oxoid web site